A study in Nature Communications by Olivier Elemento and colleagues suggests that global changes in cancer cells' epigenome may be a powerful force in determining disease progression Read more
A paper in Nature from Mark Rubin, Sandra Shin and Juan Miguel Mosquera underscores the importance of independent study validation and careful assay development. Read more
Mark A. Rubin, director of the Institute for Precision Medicine, writes in Nature about the practicalities of realizing the potential of precision medicine. Read more
A team of researchers led by Giorgio Inghirami has discovered a pair of genetic mutations that drive tumor growth in patients who have a deadly subtype of T-cell lymphoma. Read more
Harold Varmus, M.D., pens a guest piece in the New York Daily News about the remarkable progress made in cancer research and the daunting road ahead. Read more